Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeWages, Salaries and Other
Others
Wages, Salaries and Other
Ratios

Sagimet Biosciences (SGMT) Shares Outstanding (2023 - 2024)

Sagimet Biosciences has reported Shares Outstanding over the past 2 years, most recently at $30.7 million for Q3 2024.

  • Quarterly results put Shares Outstanding at $30.7 million for Q3 2024, up 43.51% from a year ago — trailing twelve months through Sep 2024 was $30.7 million (up 43.51% YoY), and the annual figure for FY2023 was $21.4 million, changed.
  • Shares Outstanding for Q3 2024 was $30.7 million at Sagimet Biosciences, up from $1.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding for SGMT hit a ceiling of $30.7 million in Q3 2024 and a floor of $185084.0 in Q1 2023.